AP-3RT + Cag

Reta + C in Laboratory Research

Reta + C is a pre-blended combination of AP-3RT — a incretin / GIP / glucagon triple agonist — and Cag, a long-acting amylin analog. The two are combined to study multi-receptor metabolic signalling from a single, consistently prepared vial.

It is offered in three ratios — 10 mg / 2.5 mg, 20 mg / 5 mg and 30 mg / 7.5 mg — so research designs can vary the relative contribution of each component.

Research Applications & Study Focus

Typical applications include comparative receptor-pharmacology panels, downstream signalling assays, and metabolic-pathway characterisation that examines the incretin and amylin pathways together rather than in isolation.

Each component is assayed separately where a certificate is available, so the composition of every vial is defined.

Purity, Handling & Verification

Supplied as a sealed, lyophilized vial for laboratory use. Where a third-party certificate of analysis is available for a batch, it is published on our Certificates of Analysis page against the lot number. Store the lyophilized material cool, dry and out of direct light, and reconstitute with reconstitution Solution under standard aseptic laboratory practice.

This material is offered strictly for in vitro laboratory research use only. It is not for human or veterinary consumption, and not for diagnostic or therapeutic use.

Technical Specifications

• Components (CAS number / molecular weight): AP-3RT (CAS 2381089-83-2, 4731.37 g/mol) + Cag (CAS 1415456-99-3, ~4409 g/mol)